Sandra M. Gurrola - 21 Jun 2025 Form 4 Insider Report for Ernexa Therapeutics Inc. (ERNA)

Role
Sr. VP of Finance
Signature
/s/ Sandra Gurrola
Issuer symbol
ERNA
Transactions as of
21 Jun 2025
Net transactions value
$0
Form type
4
Filing time
07 Jul 2025, 20:00:05 UTC
Previous filing
10 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gurrola Sandra M Sr. VP of Finance C/O ERNEXA THERAPEUTICS INC., 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE /s/ Sandra Gurrola 07 Jul 2025 0001618457

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ERNA Common Stock Options Exercise +30 +38% 110 21 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERNA Restricted Stock Units Options Exercise $0 +30 $0.000000 0 21 Jun 2025 Common Stock 30 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit converts into one share of common stock.
F2 On June 21, 2021, the reporting person was granted 118 restricted stock units, vesting in four substantially equal installments beginning on the first anniversary of the grant date.